Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-20

Clinical Trial Update: Study of Single Doses of SBT777101 in Subjects With Hidradenitis Suppurativa [Phase 1]

View source ↗

Summary

Phase 1 study update showing single-dose evaluation of SBT777101 in adults with hidradenitis suppurativa; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SBT777101

Snippet

Sponsor: Sonoma Biotherapeutics, Inc. | Conditions: Hidradenitis Suppurativa | Phase 1 | Status: ACTIVE_NOT_RECRUITING